Prevalence of subclinical infectious agents in a blood donor population tested on every donation

被引:1
|
作者
Correia, B. [1 ]
Magalhaes, A. [1 ]
Rocha, L. [1 ]
Cardoso, I. [2 ]
Ferreira, R. R. F. [2 ]
Mesa-Sanchez, I. [3 ]
机构
[1] Banco Sangue Anim, NIV Nucleo Invest Vet, Rua Dr Eduardo Santos Silva 261 AH, P-4200283 Porto, Portugal
[2] BSA Banco Sangue Anim, Rua Joao de Deus 741, P-4100462 Porto, Portugal
[3] BSA Banco Sangre Anim, Passatge Rovira I Virgili 9 Sabadell, Barcelona 08205, Spain
关键词
BABESIA; CANINE; TRANSFUSION; DOGS; TRANSMISSION;
D O I
10.1111/jsap.13698
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
ObjectivesThis study aimed to assess the prevalence of blood-borne infectious agents in healthy, client-owned dogs from a blood donor population in Portugal and Spain, and to address the importance of a screening protocol on every donation.Materials and MethodsClient-owned healthy dogs were tested before each donation on a veterinary blood bank. Blood samples from new potential donors, and from regular donors, were tested by real-time polymerase chain reaction for Leishmania species, Ehrlichia species, Brucella species, Babesia species and Anaplasma species Serological tests were also performed for Leishmania species, Ehrlichia species and Dirofilaria immitis. All donors were tested for every infectious agent in each donation.ResultsThe study found that out of a total of 8036 donors and 35,120 samples tested, 3.9% of blood donors tested positive for at least one of the agents, with the most prevalent being Anaplasma species (2.1%). Serological tests also revealed positive results in 14.0% of donors, with the highest percentage for Leishmania species (7.7%). Moreover, the study found that 28.2% of positive results were from dogs with negative results in donations performed 3 to 12 months before, and 18.0% of positive results were recent infections.Clinical SignificanceThese findings indicate a high prevalence of infectious agents in seemingly healthy, selected dogs eligible to become blood donors in the Iberian Peninsula, highlighting the importance of regular testing on every donation. This study emphasises the importance of a regular screening protocol for every donation instead of annual testing, as is commonly performed in veterinary medicine.
引用
收藏
页码:176 / 180
页数:5
相关论文
共 50 条
  • [1] Prevalence of Infectious Disease Markers in the Georgian Blood Donor Population in 2006-2011
    Avalishvili, L.
    Abashidze, M.
    Lok, V.
    Poirier, B.
    [J]. TRANSFUSION, 2012, 52 : 101A - 101A
  • [2] Quantitative estimate of the risk of blood donation contamination by infectious agents
    Pillonel, J.
    Brouard, C.
    Laperche, S.
    Barin, F.
    Bernillon, P.
    de Valk, H.
    [J]. TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2009, 16 (02) : 138 - 145
  • [3] Prevalence of blood donation eligibility in Australia: A population survey
    Mowat, Yasmin
    Hoad, Veronica
    Haire, Bridget
    Masser, Barbara
    Kaldor, John
    Heywood, Anita
    Thorpe, Rachel
    McManus, Hamish
    McGregor, Skye
    [J]. TRANSFUSION, 2023, 63 (08) : 1519 - 1527
  • [4] Prevalence of monoclonal components in a blood donor population
    Frezzotti, Annarita
    Galeazzi, Morena
    Paladini, Claudio
    Tocchini, Massimo
    Riganello, Gianluca
    Piani, Mario
    [J]. BIOCHIMICA CLINICA, 2014, 38 (04) : 292 - 294
  • [5] Prevalence and causes of blood donor deferrals among clients presenting for blood donation in northern Tanzania
    Valerian, Donath Mkenda
    Mauka, Wilhellmuss, I
    Kajeguka, Debora Charles
    Mgabo, Maseke
    Juma, Abdu
    Baliyima, Lelo
    Sigalla, Geofrey Nimrod
    [J]. PLOS ONE, 2018, 13 (10):
  • [6] PRE-DONATION BLOOD DONOR DEFERRAL: A PERSPECTIVE IN RURAL POPULATION OF INDIA
    Gupta, V
    Vagha, S. J.
    [J]. VOX SANGUINIS, 2010, 99 : 145 - 146
  • [7] Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology
    Engelfriet, CP
    Reesink, HW
    Hernandez, JM
    Sauleda, S
    O'Riordan, J
    Prati, D
    Mozzi, F
    Lin, CK
    Cuypers, HT
    Vranckx, R
    Yoshizawa, H
    Tomono, T
    Flanagan, P
    Sabino, EC
    Politis, C
    Tegtmeier, GE
    Carasa, MAV
    Hewlett, IK
    Yu, MYW
    Epstein, JS
    Eglin, R
    Barbara, J
    Coste, J
    Cornillot, C
    Hyland, CA
    Heier, HE
    Jeansson, S
    Ekermo, B
    Jarvis, LM
    Krusius, T
    Wesberg, S
    Bird, AR
    Levicnik-Stezinar, S
    Mayr-Wohlfart, U
    Cardoso, MD
    Koerner, K
    Kubanek, B
    Gessner, M
    Zerlauth, G
    [J]. VOX SANGUINIS, 2002, 82 (02) : 87 - 111
  • [8] PREVALENCE OF BABESIA ANTIBODY IN A SELECTED BLOOD-DONOR POPULATION
    POPOVSKY, MA
    LINDBERG, LE
    SYREK, A
    PAGE, PL
    [J]. TRANSFUSION, 1986, 26 (06) : 579 - 579
  • [9] PREVALENCE OF BABESIA ANTIBODY IN A SELECTED BLOOD-DONOR POPULATION
    POPOVSKY, MA
    LINDBERG, LE
    SYREK, AL
    PAGE, PL
    [J]. TRANSFUSION, 1988, 28 (01) : 59 - 61
  • [10] Prevalence of factor V Leiden in a Canadian blood donor population
    Lee, DH
    Henderson, PA
    Blajchman, MA
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 1996, 155 (03) : 285 - 289